➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Merck
Harvard Business School
Colorcon
AstraZeneca

Last Updated: March 1, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Ambroxol

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Ambroxol?

Ambroxol is an investigational drug.

There have been 24 clinical trials for Ambroxol. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2007.

The most common disease conditions in clinical trials are Pharyngitis, Dementia, and Parkinson Disease. The leading clinical trial sponsors are Boehringer Ingelheim, Hyundai Pharmaceutical Co., LTD., and Lawson Health Research Institute.

Recent Clinical Trials for Ambroxol
TitleSponsorPhase
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical TrialHelse-Bergen HFPhase 2
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical TrialKLINBEFORSKPhase 2
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical TrialHelse FonnaPhase 2

See all Ambroxol clinical trials

Clinical Trial Summary for Ambroxol

Top disease conditions for Ambroxol
Top clinical trial sponsors for Ambroxol

See all Ambroxol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Merck
Harvard Business School
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.